- Home
- HAFC vs LXEO Comparison
HAFC vs LXEO Comparison
Compare HAFC & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | HAFC | LXEO |
|---|---|---|
| Founded | 1982 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 758.9M | 663.5M |
| IPO Year | 1996 | 2023 |
Fundamental Metrics
Financial Performance| Metric | HAFC | LXEO |
|---|---|---|
| Price | $27.90 | $9.46 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | ★ $28.50 | $18.90 |
| AVG Volume (30 Days) | 378.1K | ★ 1.5M |
| Earning Date | 01-27-2026 | 11-05-2025 |
| Dividend Yield | ★ 3.92% | N/A |
| EPS Growth | ★ 15.36 | N/A |
| EPS | ★ 2.40 | N/A |
| Revenue | ★ $246,352,000.00 | N/A |
| Revenue This Year | $19.61 | N/A |
| Revenue Next Year | $11.05 | N/A |
| P/E Ratio | $11.49 | ★ N/A |
| Revenue Growth | ★ 5.84 | N/A |
| 52 Week Low | $19.25 | $1.45 |
| 52 Week High | $29.46 | $10.99 |
Technical Indicators
Market Signals| Indicator | HAFC | LXEO |
|---|---|---|
| Relative Strength Index (RSI) | 52.22 | 47.35 |
| Support Level | $26.51 | $8.93 |
| Resistance Level | $27.71 | $10.33 |
| Average True Range (ATR) | 0.52 | 0.67 |
| MACD | -0.10 | -0.10 |
| Stochastic Oscillator | 52.96 | 26.86 |
Price Performance
Historical ComparisonAbout HAFC Hanmi Financial Corporation
Hanmi Financial Corp is a Los Angeles-based bank that caters to Korean-Americans and other multi-ethnic communities across California, Colorado, Georgia, Illinois, New Jersey, New York, Texas, Virginia, and Washington. The bank mainly focuses on small businesses and commercial and real estate loans. It also offers a variety of international finance and trade services and products, including letters of credit, import financing, and export financing. The Bank's revenues are derived from interest and fees on loans, interest, and dividends on the securities portfolio, service charges on deposit accounts, and sales of SBA loans.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.